Plotnikov Mark B, Aliev Oleg I, Nosarev Alexey V, Shamanaev Alexander Y, Sidekhmenova Anastasia V, Anfinogenova Yana, Anishchenko Anna M, Pushkina Ekaterina V
E.D. Goldberg Institute of Pharmacology and Regenerative Medicine, Russian Academy of Sciences, Tomsk, Russia.
Siberian State Medical University, Tomsk, Russia.
Biorheology. 2016 Jul 26;53(2):93-107. doi: 10.3233/BIR-15100.
Systemic arterial pressure (AP) depends on two physiological variables: cardiac output (CO) and total peripheral resistance (TPR). The latter depends on vascular hindrance and blood viscosity (BV). However, the relative contributions of the vascular and rheological factors to TPR remain unclear.
The aim of our work was to study the haemodynamic and haemorheologic effects of a treatment course with pentoxifylline (PTX) in SHRs in an effort to assess the impact of the rheological factor on TPR and AP.
The effects of the treatment course with PTX (100 mg/kg/day p.o. for six weeks) on BV, plasma viscosity, haematocrit, erythrocyte aggregation and deformability, mean AP (MAP), stroke volume (SV), CO, and TPR were studied in SHRs and in control Wistar Kyoto (WKY) rats.
PTX-treated SHRs had a lower BV, lower erythrocyte aggregation, and higher erythrocyte deformability index compared with the controls. The TPR level was higher by 43% compared with that in WKY rats and did not differ from the values obtained from control SHRs. In SHRs, moderate and strong positive correlations were found between BV and MAP and between BV and TPR. PTX-treated SHRs did not have any significant correlations between the above mentioned parameters.
Treatment with PTX attenuated whole blood viscosity, but did not affect the AP and hemodynamic parameters in the experimental SHRs compared with the control SHRs. The magnitude of the rheologic effects of PTX was insufficient to cause appreciable decreases in TPR and AP.
体循环动脉压(AP)取决于两个生理变量:心输出量(CO)和总外周阻力(TPR)。后者取决于血管阻力和血液粘度(BV)。然而,血管因素和流变学因素对TPR的相对贡献仍不清楚。
我们研究的目的是探讨己酮可可碱(PTX)治疗疗程对自发性高血压大鼠(SHRs)的血流动力学和血液流变学影响,以评估流变学因素对TPR和AP的影响。
研究了PTX治疗疗程(100mg/kg/天,口服,持续六周)对SHRs和对照Wistar Kyoto(WKY)大鼠的BV、血浆粘度、血细胞比容、红细胞聚集性和变形性、平均动脉压(MAP)、每搏输出量(SV)、CO和TPR的影响。
与对照组相比,PTX治疗的SHRs的BV较低,红细胞聚集性较低,红细胞变形性指数较高。TPR水平比WKY大鼠高43%,与对照SHRs的值无差异。在SHRs中,BV与MAP以及BV与TPR之间存在中度和强正相关。PTX治疗的SHRs上述参数之间无显著相关性。
与对照SHRs相比,PTX治疗可降低全血粘度,但不影响实验性SHRs的AP和血流动力学参数。PTX的流变学效应大小不足以导致TPR和AP明显降低。